Condition
Symptom, Behavioral
Total Trials
4
Recruiting
1
Active
2
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Active Not Recruiting1
Unknown1
Completed1
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT04379414Not ApplicableActive Not Recruiting
YES Study - Newly Diagnosed/Metastatic Intervention
NCT06444321Not ApplicableRecruiting
INTEgRated Health CARE for Patients With Frailty and Heart Failure
NCT05667571Completed
Symptom Communication in Advanced Cancer
NCT04388735Unknown
Multiple Myeloma (MM) Quality of Life (QOL) Study
Showing all 4 trials